ABSTRACT
Gallbladder cancer is a common type of biliary tract tumor. Optimal management for early stage cases typically involves radical excision as the primary treatment modality. Various surgical techniques, including laparoscopic, robotic, and navigational surgery, have demonstrated favorable clinical outcomes in radical gallbladder excision. Unfortunately, most patients are ineligible for surgical intervention because of the advanced stage of the disease upon diagnosis. Consequently, non-surgical interventions, such as chemotherapy, radiotherapy, immunotherapy, and targeted therapy, have become the mainstay of treatment for patients in advanced stages. This review focuses on elucidating various surgical techniques as well as advancements in immunotherapy and targeted therapy in the context of recent advancements in gallbladder cancer research.
Declaration of financial/other relationships
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. Peer reviewers on this manuscript have received an honorarium from IPGM for their review work but have no other relevant financial relationships to disclose.
Acknowledgments
We express our gratitude to all the participants who participated in the study.
Author contributions
Yanjun Sun: conceptualization, writing – original draft; Junfeng Gong: conceptualization, writing – original draft; Zhuang Li: writing – original draft; Lin Han: supervision, writing – review and editing; Dengqun Sun: supervision, writing, review, and editing.